1. Home
  2. ALUR vs RLYB Comparison

ALUR vs RLYB Comparison

Compare ALUR & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • RLYB
  • Stock Information
  • Founded
  • ALUR 2009
  • RLYB 2018
  • Country
  • ALUR United States
  • RLYB United States
  • Employees
  • ALUR N/A
  • RLYB N/A
  • Industry
  • ALUR
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALUR
  • RLYB Health Care
  • Exchange
  • ALUR Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • ALUR 22.5M
  • RLYB 42.7M
  • IPO Year
  • ALUR N/A
  • RLYB 2021
  • Fundamental
  • Price
  • ALUR $3.14
  • RLYB $0.89
  • Analyst Decision
  • ALUR Strong Buy
  • RLYB Buy
  • Analyst Count
  • ALUR 4
  • RLYB 6
  • Target Price
  • ALUR $75.00
  • RLYB $8.10
  • AVG Volume (30 Days)
  • ALUR 67.5K
  • RLYB 105.4K
  • Earning Date
  • ALUR 11-13-2024
  • RLYB 11-07-2024
  • Dividend Yield
  • ALUR N/A
  • RLYB N/A
  • EPS Growth
  • ALUR N/A
  • RLYB N/A
  • EPS
  • ALUR N/A
  • RLYB N/A
  • Revenue
  • ALUR $34,754,000.00
  • RLYB $598,000.00
  • Revenue This Year
  • ALUR N/A
  • RLYB N/A
  • Revenue Next Year
  • ALUR $2.22
  • RLYB N/A
  • P/E Ratio
  • ALUR N/A
  • RLYB N/A
  • Revenue Growth
  • ALUR N/A
  • RLYB N/A
  • 52 Week Low
  • ALUR $2.72
  • RLYB $0.84
  • 52 Week High
  • ALUR $98.75
  • RLYB $3.46
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 26.80
  • RLYB 38.60
  • Support Level
  • ALUR $2.72
  • RLYB $0.84
  • Resistance Level
  • ALUR $9.10
  • RLYB $1.08
  • Average True Range (ATR)
  • ALUR 2.10
  • RLYB 0.08
  • MACD
  • ALUR -0.60
  • RLYB -0.00
  • Stochastic Oscillator
  • ALUR 3.81
  • RLYB 20.50

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: